Herb ·Strong evidence ·Reviewed May 2026
Resin extract with potent anti-inflammatory properties, especially for joints.
The bottom line
Evidence rating strong. Most-documented uses: joint health, anti-inflammatory, gut health. 19 sources indexed (2003–2025), with 8 interaction records on file.
Core mechanism
Boswellic acids (especially AKBA) inhibit 5-lipoxygenase (5-LOX), blocking leukotriene synthesis. Also inhibits NF-κB and reduces TNF-alpha. Joint-specific anti-inflammatory action.15,17
Take with fat-containing meal for absorption
Dosing protocol
Standardization to AKBA matters more than total boswellic acids.
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes AKBA-Enriched Boswellia Extract.
Assumes 300-500 mg 3 times daily. Vendor basis: NOW/iHerb, Vitacost, Thorne, and Life Extension; AKBA-enriched extracts drive premium pricing. Updated 2026-05-28.
How much you'd eat to match a supplemental dose.
Boswellia is a resin extract standardized for boswellic acids, not a common edible food.
What to test, the optimal window inside the conventional range, and how long a response takes.
Boswellia serrata (100 to 300 mg per day of AKBA-standardized extract) lowers hsCRP and improves WOMAC pain scores in osteoarthritis RCTs.8,10
Standardization to acetyl-11-keto-beta-boswellic acid (AKBA) matters more than total boswellic acids. 5-Loxin and ApresFlex are well-studied extracts.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Boswellic acids inhibit 5-lipoxygenase, reducing leukotriene-driven joint inflammation and improving pain and function in knee osteoarthritis.15,8
Several RCTs show pain and mobility benefit over weeks; effect builds gradually, so allow 4 to 8 weeks before judging.
Boswellic acids inhibit 5-lipoxygenase and leukotriene synthesis, an anti inflammatory pathway relevant to joint stiffness.15,16
Often combined with curcumin; generally well tolerated, with occasional mild GI upset.
Boswellic acids inhibit 5-lipoxygenase and leukotriene synthesis, with moderate evidence for reducing joint and spinal inflammatory pain.15,7
Best studied in osteoarthritis; pairs well with curcumin for additive anti-inflammatory effect.
Boswellia targets leukotriene-related inflammation and is widely used for joint comfort.1,5
Often pairs well with curcumin.
Boswellia targets leukotriene-related inflammation and is widely used for joint and inflammatory support.7,15
Often paired with curcumin.
Boswellic acids inhibit the 5-LOX inflammatory pathway and may reduce joint and connective tissue pain in some trials.15,16
Look for products standardized to AKBA rather than total boswellic acids.
5-lipoxygenase inhibition by boswellic acids reduces leukotriene-driven inflammation, with small studies suggesting symptom relief in inflammatory arthritis.15,17
Human RA data are limited; reasonable adjunct for symptom relief alongside DMARDs, not a disease-modifying agent.
Boswellic acid inhibition of 5-lipoxygenase reduces leukotriene-mediated inflammation, a plausible mechanism for easing inflammatory back pain and stiffness.9
Mechanistically reasonable but lacks AS-specific human trials; consider only as a low-risk add-on to standard care.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
Both reduce joint inflammation through complementary pathways; head-to-head trials show additive benefit in osteoarthritis.
Recommendation: Common stack for joint health: boswellia 100 to 300 mg AKBA extract plus curcumin phytosome 500 to 1000 mg per day.
Combining chondroitin with boswellia may provide complementary anti-inflammatory and cartilage-supportive effects in osteoarthritis.
Recommendation: Reasonable to combine for joint support. Allow several weeks to evaluate symptomatic response.
MSM and Boswellia work through complementary anti-inflammatory pathways and are often combined for joint and soft-tissue comfort, with some studies suggesting additive symptom relief.
Recommendation: Reasonable to combine for inflammatory joint support. Take with food and monitor for mild digestive upset.
Pairing provides complementary anti-inflammatory action, with Boswellia inhibiting 5-lipoxygenase and Cat's Claw suppressing NF-kB signaling.
Recommendation: Reasonable to combine for joint and inflammatory support. No timing constraint needed; take with food to improve tolerability.
The pair targets joint discomfort through distinct routes, with Boswellia dampening inflammatory signaling and Glucosamine supplying a building block for cartilage matrix, so the combination addresses both inflammation and structural support.
Recommendation: Reasonable to take together for osteoarthritis support. Use a standardized Boswellia extract (for example one enriched for AKBA) at the label dose alongside glucosamine sulfate 1500mg per day. No timing separation is needed.
Ginger and boswellia reduce inflammation through different enzyme pathways, so combining them may give broader anti-inflammatory and joint-symptom relief than either alone.
Recommendation: Reasonable to combine for joint or inflammatory support. Use standardized extracts at label doses and monitor for additive GI upset.
Combined use produces greater anti-inflammatory and joint symptom relief than either agent alone in osteoarthritis studies.
Recommendation: Reasonable to take together for joint or inflammatory support; standardized extracts (curcuminoids plus boswellic acids) are commonly co-formulated and can be dosed at the same time.
Boswellia serrata extracts inhibit CYP2C9, CYP3A4, and CYP2C19, the isoenzymes responsible for warfarin metabolism. Spontaneous postoperative bleeding, hematomas, hematemesis, melena, and subarachnoid hemorrhage have been reported in warfarin patients who added boswellia. Boswellic acids also inhibit COX-1 and 5-lipoxygenase, adding a pharmacodynamic antiplatelet component.
Recommendation: Avoid boswellia supplements while taking warfarin. If you are already taking both, do not stop abruptly without telling your anticoagulation clinic, and arrange an INR check within 1-2 weeks.
Numbered references. Citations throughout the page link here.
Meta-analysis of RCTs showed Boswellia serrata extract significantly reduced pain (WOMAC pain scores) and improved physical function in osteoarthritis patients compared to placebo.
Meta-analysis confirmed Boswellia serrata extracts have significant anti-inflammatory effects, reducing inflammatory biomarkers and improving clinical outcomes in inflammatory conditions.
Dalmonte T, Andreani G, Rudelli C et al.. Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis. Phytotherapy research : PTR. 2024
Meta-analysis found Boswellia serrata extract improved clinical outcomes and reduced inflammatory markers in patients with Crohn's disease and ulcerative colitis.
Meta-analysis of 11 RCTs (N=1009) found boswellia significantly more effective than placebo for pain relief and functional improvement with a recommended treatment duration of at least 4 weeks
Majumdar A, Prasad MAVV, Gandavarapu SR et al.. Efficacy and safety evaluation of Boswellia serrata and Curcuma longa extract combination in the management of chronic lower back pain: A randomised, double-blind, placebo-controlled clinical study. Explore (New York, N.Y.). 2025
Kumar B, Ghaytidak AB, Pandey AK et al.. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study. Journal of the American Nutrition Association. 2025
Mamatha K, Prabhakaran P, Syam Das S et al.. A full-spectrum Boswellia serrata extract with enhanced bioavailability, and its co-delivered system with curcumin alleviate pain and stiffness associated with moderate spondylitis: a randomized double-blind, placebo-controlled, 3-arm study. Frontiers in pharmacology. 2025
Standardized Boswellia serrata extract demonstrated large clinically important effects for pain reduction at short term, with improvements visible within five days
Majeed M, Majeed S, Narayanan NK et al.. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytotherapy research : PTR. 2019
5-Loxin (AKBA-enriched boswellia extract) significantly improved pain scores and physical function in osteoarthritis patients with no safety concerns
Boswellic acids inhibit 5-lipoxygenase, leukotriene synthesis, prostaglandin synthesis, NF-kappaB, and reduce pro-inflammatory cytokines including IL-1, IL-2, IL-6, IFN-gamma and TNF-alpha
Boswellic acids and B. serrata extract are safe agents with multiple beneficial anti-inflammatory activities, though pharmacokinetic data suggest poor oral bioavailability of AKBA
AKBA potently inhibits 5-lipoxygenase product formation with an IC50 of 1.5 microM at a novel pentacyclic triterpene binding site distinct from the substrate site
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
NutriStack